Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
Condition(s):COVID-19; Virus Diseases; Corona Virus InfectionLast Updated:January 11, 2021Completed
Hide Studies Not Open or Pending
Condition(s):COVID-19; Virus Diseases; Corona Virus InfectionLast Updated:January 11, 2021Completed
Condition(s):HealthyLast Updated:May 18, 2022Completed
Condition(s):Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination Therapy vs. Oseltamivir Alone for Hospitalised Paediatric Influenza PatientsLast Updated:March 19, 2020Completed
Condition(s):Narcolepsy Without Cataplexy; Idiopathic HypersomniaLast Updated:June 21, 2022Recruiting
Condition(s):Drug Interaction StudyLast Updated:January 29, 2020Completed
Condition(s):HealthyLast Updated:December 15, 2016Completed
Condition(s):Multidrug-resistant Tuberculosis; Extensively Drug-resistant TuberculosisLast Updated:July 1, 2013Completed
Condition(s):CLARITHROMYCIN/DILTIAZEM [VA Drug Interaction]Last Updated:April 14, 2014Completed
Condition(s):Sepsis; Severe Sepsis; Septic ShockLast Updated:August 4, 2011Completed
Condition(s):Sepsis; Pneumonia; Gram-Negative Bacteria Infection; Multiple Organ Failure; Respiratory Distress Syndrome; Mortality; BiomarkersLast Updated:December 22, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.